CBL Chemobau Industrieboden GmbH generated the majority of its revenue from the installation and renovation of high-strength industrial floors for industrial, logistics and commercial clients. Its service offering covers the full industrial floor spectrum: from robust concrete floors via multifunctional screeds to high-quality resin coatings and sealing works. In fiscal 2023 most revenue was earned domestically, the company recorded foreign sales again for the first time since 2019 (foreign sales share 2.03 %) and employed on average 98 staff. Total performance in 2023 amounted to EUR 65.3 million, net income was EUR 3,300,869.44 and equity rose to EUR 12,489,999.64 as of 31 December 2023, placing the company among the largest in the German industrial floor sector. CBL Chemobau Industrieboden GmbH is a family business.
Durchführung von Bauarbeiten, wie Herstellung von Industrieboden, Ausführung von Abdichtungsarbeiten, Kunststoff-Beschichtungen und -Imprägnierungen sowie ähnliche Arbeiten, unter bevorzugter Verwendung von Erzeugnissen, Systemen und Verfahrenstechniken der Firma Chemotechnik Gesellschaft für Baustoff-Chemie mbH & Co. in Abstatt. Die Gesellschaft kann sich an anderen Unternehmen beteiligen.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 102147 (as of 30 October 2026)
| Name | Type | City |
|---|---|---|
| Daniel Schmiech | Geschäftsführer(in) | Leingarten |
| Oliver Schmiech | Geschäftsführer(in) | Leingarten |
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 102147 (as of 30 October 2026)
| Date | Event Type | Event |
|---|---|---|
| 19.01.2021 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| 11.08.2016 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| 08.11.2012 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 16.11.2006 | Share Capital Set | — | 512.000 € |
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 102147 (as of 30 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | Rohergebnis€15.1M2 | €1,836,309 | €20,654,454 | — |
| 2023 | Rohergebnis€19M2 | €3,322,384 | €23,667,108 | — |
| 2022 | €59,089,853 | €857,550 | €19,007,721 | — |
| 2021 | €43,661,082 | €755,881 | €16,124,163 | — |
| 2020 | Rohergebnis€16.5M2 | €1,919,332 | €17,240,431 | — |
| 2019 | Rohergebnis€13.3M2 | €1,026,974 | €12,402,328 | — |
| 2018 | Rohergebnis€13.4M2 | €1,740,107 | €16,285,314 | — |
| 2017 | Rohergebnis€13.3M2 | €1,280,357 | €16,532,861 | — |
| 2016 | Rohergebnis€12.7M2 | €1,052,399 | €15,070,564 | — |
| 2015 | Rohergebnis€13.1M2 | €1,726,340 | €13,671,540 | — |
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 102147 (as of 30 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €7,994,175 | 98.6% |
| Depreciation | €61,884 | 0.8% |
| Interest & Similar | €54,750 | 0.7% |
